News

Ryzodeg Listing on the PBS statement

Diabetes Australia applauds the decision by Health Minister Greg Hunt and the Federal Government to list Ryzodeg on the Pharmaceutical Benefits Scheme (PBS) from 30 July 2018.

Ryzodeg is a combination of ultra-long acting and rapid-acting insulin delivered in a once-daily injection that will eliminate the need for multiple daily injections and make diabetes management easier and less intrusive for some people.

Insulin injections are one of the most intrusive parts of living with diabetes. All people living with type 1 diabetes who are not using insulin pumps and many people with type 2 diabetes have to inject themselves with insulin multiple times during the day.

Investigating the link between type 2 diabetes and dementia

Every day scientists are learning more about the links between type 2 diabetes and dementia. Both conditions can have a major impact on a person’s quality of life as they age.

This why Diabetes Australia is supporting research into how a process known as oxidative stress contributes to the development of both conditions.

Dr Camilla Hoyos from the University of Sydney is leading a project which is using MRI scanning to assess levels of oxidative stress within the brain.

People with diabetes could be big winners from My Health Record

Australians with all types of diabetes, who often see a range of health professionals to manage their condition, could see the biggest health benefits from having a My Health Record.

My Health Record is an online health record, that enables the safe storage, access and sharing of important health information. It will improve communication between GPs, endocrinologists (diabetes specialists), diabetes educators, optometrists, podiatrists and other health professionals that provide care to people with diabetes.

Peak Health Groups Welcome Government Funding for New National Diabetes Eye Screening Program to Prevent Blindness

Leading diabetes and eye health groups today applauded the Australian Government funding announcement for a new national diabetes eye screening program to reduce vision loss and blindness in people with diabetes.

The Australian-first initiative program is a major step in the fight against diabetes related blindness and will enable early detection and treatment to protect the sight of over 1.2 million Australians living with diabetes.

Failure to detect type 2 diabetes early costing $700 million per year

Diabetes Australia has warned that failure to implement a comprehensive national type 2 diabetes early detection program could be costing the Australian health system more than $700 million each year.

Diabetes Australia is calling for emergency departments and GP clinics across Australia to conduct more routine detection in a bid to diagnose up to 500,000 Australians who may currently have silent, undiagnosed type 2 diabetes.

People can have type 2 diabetes for up to seven years before it is diagnosed and in that time many people will begin to develop debilitating complications including heart attacks and strokes, eye damage and blindness, foot ulcers and limb amputation, and kidney damage. In many cases, complications can be prevented with early detection and optimal treatment.

of 38